Biotech Values : PFE starts phase-2 trial of PF-07081532,...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

Biotech Values

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	843
Posts	122860
Boards Moderated	9
Alias Born	09/05/2002

Re: DewDiligence post# 243899

Tuesday, 12/20/2022 7:30:54 PM

Tuesday, December 20, 2022 7:30:54 PM

PFE starts phase-2 trial of PF-07081532, one of the two oral GLP-1 candidates PFE is testing for treatment of obesity and T2D:

https://www.globenewswire.com/news-release/2022/12/21/2577552/0/en/Sosei-Heptares-Partner-Pfizer-Progresses-its-Oral-GLP-1-Receptor-Agonist-PF-07081532-into-Phase-2-Clinical-Trials-for-Treating-Type-2-Diabetes-and-Obesity.html

Please see #msg-170009357 and #msg-170010898 for background.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Keep Last Read

Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow